Brief: Anika Therapeutics Q3 Revenue USD 38.753 Million
31/10/2024 11:05
Oct 31 (Reuters) - Anika Therapeutics Q3 net income USD -29.918 million. * Q3 pretax profit USD -27.611 million * Q3 income from operations USD -28.017 million * Q3 gross profit USD 1.44 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%